These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34608117)

  • 1. COVID-19 and its effects on neurological functions.
    Yew MMT; Lip JQ; Ling APK
    Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
    Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
    Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19 and oral diseases: Crosstalk, synergy or association?
    Brandini DA; Takamiya AS; Thakkar P; Schaller S; Rahat R; Naqvi AR
    Rev Med Virol; 2021 Nov; 31(6):e2226. PubMed ID: 33646645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
    Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
    Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
    Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
    Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS implications of COVID-19: a comprehensive review.
    Nagu P; Parashar A; Behl T; Mehta V
    Rev Neurosci; 2021 Feb; 32(2):219-234. PubMed ID: 33550782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
    De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
    Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
    Hu J; Jolkkonen J; Zhao C
    Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
    Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningitis as an Initial Presentation of COVID-19: A Case Report.
    Naz S; Hanif M; Haider MA; Ali MJ; Ahmed MU; Saleem S
    Front Public Health; 2020; 8():474. PubMed ID: 33072684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging (MRI) and neurological manifestations in SARS-CoV-2 patients.
    Meo SA; Abukhalaf AA; Alomar AA; Al-Hussain F
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1101-1108. PubMed ID: 33577067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection and stroke risk.
    Sadeghmousavi S; Rezaei N
    Rev Neurosci; 2021 Apr; 32(3):341-349. PubMed ID: 33580645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.